Friday, 13 November 2020
Meeting category
Date(s)
13 Nov 2020
Meeting type
Virtual Meeting
Organizer
Nurses & Pharmacists HIV Clinical Forum 2020
Enduring Materials
Program
- 10:00
10:00 CET
Introductions, and Goals
Session 1: Caring for HIV Patients in COVID 19 Era -
Nadia Naous, PGDip, GPP, MRPharmS
Session Chair
Laura Waters, MD, FRCP
Central & North West London NHS Trust, United Kingdom
10:20 CET
Challenges in Routine HIV Care in the COVID-19 Era
10:35 CET
Running an HIV Clinic in the COVID-19 Era - Nurses Role
Eileen Nixon, PhD
Brighton and Sussex University Hospitals, United Kingdom
10:50 CET
Round Table - Meeting the Challenge in Different Countries: How to Run the HIV Clinic in the COVID-19 Era
Moderator: Sally Hargreaves, PhD, FRCPE
St George's, University of London, United Kingdom
Chelsea and Westminster Hospital NHS Foundation Trust, United Kingdom
Leonie Meemken, PhD
ifi-Institute for Interdisciplinary Medicine, Germany
Riccardo Rondina, Rn
Azienda Ospedaliero-Universitaria Di Ferrara Infectious Diseases Unit, Italy
Session 2: Integrating Injectable Antiretroviral Regimens in to Routine Care -
Session Chair
11:30 CET
State-of-the-Art update on Injectable HIV Regimens
11:45 CET
Unique Challenges in Integrating Injectable Regimens During Social Distancing
12:00 CET
Brainstorming Roundtable: What Should the HIV Clinic Look Like in the Injectable Drug Era?
Moderator: Laura Waters, MD, FRCP
Central & North West London NHS Trust, United Kingdom
Martine de Haan, MSc
Radboudumc, the Netherlands
Discussion Topics:
Handling the workload of multiple visits every two months
Discussion Topics:
Logistical considerations of ordering, supply, storing and injecting on a large scale
Discussion Topics:
Patient interactions: Counseling patients on use and routine of injectables
Discussion Topics:
Dealing with poor adherence and missed visits
Session 3: Clinical Considerations in Switching Suppressed Patients -
Marta Boffito, MD, PhD, FRCP, MBA
Session Chair
13:00 CET
Switching Patients to Avoid and Mitigate Toxicity: Causes and Options
13:15 CET
Clinical Case Presentation: Switching therapy before/during pregnancy - or similar
Chelsea and Westminster Hospital NHS Foundation Trust; Imperial College London; United Kingdom
Session 4: PrEP -
Session Chair
Anton Pozniak, MD, FRCP
Chelsea and Westminster Hospital, United Kingdom
13:45 CET
State-of-the-Art update on PrEP Implemetation in European Countries
14:00 CET
Clinical Case Presentation: Community based PrEP
14:30 CET
Closing Remark
Overview
Welcome
This Nurses & Pharmacists HIV Clinical Forum provided an independent scientific program involving the world’s leading experts and is specifically designed for European Nurses and Pharmacists HIV healthcare professionals with a focus on optimizing treatment for their patients.
This program featured challenging plenary lectures followed by ample time for Q&A and debate, stimulating interaction, and the sharing of knowledge within the HIV-treating community in Europe. The program included virtual networking opportunities for community building; thus, providing delegates with the unique opportunity to meet their colleagues in a focused and scientific setting.
The HIV Clinical Forum is a series of interactive programs that provide an independent scientific program on emerging topics in HIV, involving experts where HIV clinicians and allied healthcare professionals receive updates on the latest developments related to HIV management, where they can share their clinical experience, and present results from their ongoing and completed cohorts/ research programs.
Furthermore, the HIV Clinical Forum provides an educational setting where healthcare professionals can acquire specific skills that will enhance their capabilities to interpret research results and even develop new research projects.
Program Directors
Local Chair
Scientific Chairs
Liz Foote, MSc, NMP, RGN
Sussex Community NHS Foundation Trust, United Kingdom
Nadia Naous, PGDip, GPP, MRPharmS
Chelsea and Westminster Hospital NHS Foundation Trust, United Kingdom
General Information
COVID-19 Update
The Nurses & Pharmacists HIV Clinical Forum 2020: Optimizing Treatment took place on 13 November 2020 as a fully virtual meeting. Participants attended plenary sessions and round-table discussions during the day of the meeting.
We are available to answer any questions or concerns that you may have about your participation at the Nurses & Pharmacists HIV Clinical Forum 2020: Optimizing Treatment. For more information, please contact Mrs. Dagmar Jónasdóttir at Dagmar@amededu.com.
To stay updated on developments in relation to this forum meeting, make sure you are signed up for our newsletter.
We are available to answer any questions or concerns that you may have about your participation at the Nurses & Pharmacists HIV Clinical Forum 2020: Optimizing Treatment. For more information, please contact Mrs. Dagmar Jónasdóttir at Dagmar@amededu.com.
To stay updated on developments in relation to this forum meeting, make sure you are signed up for our newsletter.
Meeting Objectives
With the HIV Clinical Forum program we aim to:
- Build a community of healthcare professionals devoted to providing optimal clinical care for their patients
- Create a platform for interactive information exchange on novel treatment options
- Translate the latest research achievements into clinical guidance for the optimal management of individuals living with HIV
- Build a community of healthcare professionals devoted to providing optimal clinical care for their patients
- Create a platform for interactive information exchange on novel treatment options
- Translate the latest research achievements into clinical guidance for the optimal management of individuals living with HIV
Learning Objectives
After participating in the HIV Clinical Forum, participants will be able to:
- Understand major considerations for HIV clinical care during the COVID 19 pandemic
- Describe the pros and cons of novel treatment and prevention options
- Understand clinical considerations in switching suppressed patients
- Know how best to integrate long-acting injectable drugs in to routine clinical care
- Identify key challenges and opportunities for community based prevention programs
- Understand major considerations for HIV clinical care during the COVID 19 pandemic
- Describe the pros and cons of novel treatment and prevention options
- Understand clinical considerations in switching suppressed patients
- Know how best to integrate long-acting injectable drugs in to routine clinical care
- Identify key challenges and opportunities for community based prevention programs
Practical Information
Certificate of Attendance
A certificate of attendance was sent by e-mail to participants shortly after the forum meeting.
Disclaimer
This forum meeting is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of meeting, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from the meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending this forum meeting.
Language
The official language of this meeting was English. Translation was not provided.
Liability and Insurance
By registering for this forum meeting, participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, as well as audio and video recordings, are not permitted at the official forum meeting sessions. Only the official medical writer, appointed by the organizer, may make recordings. All presentations will be posted on the forum website as soon as possible after the meeting is finished, provided that the speaker has given their permission to do so.
Committees
Program Directors
Local Chair
Scientific Chairs
Nadia Naous, PGDip, GPP, MRPharmS
Chelsea and Westminster Hospital NHS Foundation Trust, United Kingdom
The Program Chairs and Scientific Chairs are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the forum meeting, identify interesting topics and candidate speakers, and review all submitted abstracts.
Support
Support
The Nurses & Pharmacists HIV Clinical Forum 2020 is supported by an independent educational grant from ViiV Healthcare.
ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
Endorsers
Endorsers
Related Programs
